Sanofi-Aventis CR`s Equity And Liabilities reached 3,210 CZK mil in 2017. This is 12.1 % more than in the previous year.
Buy Equity And Liabilities data for Sanofi-Aventis Czech Republic.
$19.99Buy all data for Sanofi-Aventis Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 227 | 259 | 218 | 267 | 276 | ||||||||
Bayer Czech Republic | CZK mil | ... | ... | ... | 774 | 572 | 698 | 682 | 830 | ||||||||||
GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 3,166 | 2,418 | 2,374 | 2,019 | 2,107 | ||||||||||
Merck Czech Republic | CZK mil | ... | ... | 445 | 500 | 544 | 476 | 530 | |||||||||||
Novartis Czech Republic | CZK mil | 1,401 | 1,514 | 1,507 | 1,646 | 1,911 | |||||||||||||
Pfizer Czech Republic | CZK mil | ... | ... | 2,885 | 2,530 | 2,812 | 2,922 | 1,937 | |||||||||||
Roche Czech Republic | CZK mil | ... | ... | ... | 2,238 | 2,344 | 2,245 | 2,317 | 2,548 | ... | |||||||||
Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 3,167 | 3,297 | 2,694 | 2,348 | 2,635 | |||||||||
Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 95.4 | 110 | 251 | 284 | ||
Walmark | CZK mil | ... | ... | ... | 1,719 | 1,596 | 1,964 | 2,096 | 1,607 |